Results
1 -
10 of
71Treatment of Hepatitis C After Liver Transplantation, Hepatitis C Virus and Liver Transplantation Hepatitis B and Hepatitis C Antiviral Agents, Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions Treatment Effects and Resistance-Associated Variants of Sofosbuvir Regimen for Japanese Patients with Chronic Hepatitis C Virus Genotypes 1 and 2, Hepatitis C Virus Treatment Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapy, Journal of Gastroenterology Treatment with sofosbuvir and ledipasvir without ribavirin for 12??weeks is highly effective for recurrent hepatitis C virus genotype 1b infection after living donor liver transplantation: a Japanese multicenter experience, Journal of Gastroenterology NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b, Journal of Gastroenterology Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study, Journal of Gastroenterology Emergence of hepatitis C virus NS5A L31V plus Y93H variant upon treatment failure of daclatasvir and asunaprevir is relatively resistant to ledipasvir and NS5B polymerase nucleotide inhibitor GS-558093 in human hepatocyte chimeric mice, Journal of Gastroenterology